tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
Advertisement

Alnylam Pharma (ALNY) Similar Stocks

Compare
1,325 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$456.35
$60.38B
69.31%
22 Buy
5 Hold
0 Sell
Strong Buy
Incyte
$86.85
$16.85B
19.61
29.55%
8 Buy
9 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$403.30
$103.64B
29.22
-11.08%
15 Buy
10 Hold
0 Sell
Moderate Buy
Argenx Se
$800.00
$48.30B
37.18
47.33%
21 Buy
2 Hold
0 Sell
Strong Buy
Genmab
$33.56
$19.20B
15.91
43.42%
5 Buy
1 Hold
1 Sell
Moderate Buy
BioNTech SE
$105.49
$25.12B
-11.94%
12 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALNY
Alnylam Pharma
456.35
189.58
71.06%
INCY
Incyte
86.85
21.09
32.07%
VRTX
Vertex Pharmaceuticals
403.30
-45.30
-10.10%
ARGX
Argenx Se
800.00
277.21
53.03%
GMAB
Genmab
33.56
10.13
43.24%
BNTX
BioNTech SE
105.49
-16.06
-13.21%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis